The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
More than 3,500 participants will join the nationwide AI-focused hackathon hosted as Indian Institute of Science
With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems
Health innovations are viewed more positively than food and agricultural technologies
SRM Medical College Hospital and Research Centre hosts undergraduate research expo highlighting innovation, interdisciplinary collaboration, and the role of artificial intelligence
Subscribe To Our Newsletter & Stay Updated
